Nippon Chemiphar’s Generics Business Continues To Recover

As Japanese Company Sees 2.4% Growth In Generics Segment

 
• By Akriti Seth
  
recovery
Nippon Chemiphar is on its road to recovery with single-digit growth in generics segment • Source: Alamy

More from Earnings

More from Business